Record Revenue and EBITDA
RadNet achieved record revenue and adjusted EBITDA for Q3 2024, with total company revenue increasing by 14.7% and Digital Health revenue increasing by 34.3% compared to the previous year.
Advanced Imaging Growth
Advanced imaging represented 26.7% of procedural volume, up 142 basis points from the previous year, driven by technology advances and capital investments in advanced imaging equipment.
Digital Health Expansion
The AI-powered breast cancer screening program grew 75.8% quarter-over-quarter, contributing significantly to the Digital Health segment's growth.
New Joint Ventures and Facilities
RadNet opened 5 new facilities in 2024 and plans to open 3 more by year-end, with 15 additional projects in development for 2025. The company also expanded its joint ventures with health systems.
Collaboration with GE HealthCare
RadNet announced a collaboration with GE HealthCare to integrate AI-powered workflows and clinical solutions, starting with the SmartMammo solution for mammography.